<DOC>
	<DOCNO>NCT00004985</DOCNO>
	<brief_summary>The purpose study look effectiveness anti-HIV drug combination add capravirine patient fail first drug combination treatment .</brief_summary>
	<brief_title>Combination Treatment Using Capravirine ( AG1549 ) , Nelfinavir , Two Nucleoside Reverse Transcriptase Inhibitors HIV Patients Who Failed Initial Combination Therapy</brief_title>
	<detailed_description>[ Note : As 2/28/2001 , due toxicity study concern safety , change methodology implement patient need sign new inform consent . The study unblinded . Group 1 receive AG1549 ; Group 2 receive AG1549 placebo . Patients take capravirine currently viral load 400 copies/ml may continue take capravirine 1400 mg twice daily . Capravirine discontinue patient viral load great 400 copies/ml last visit switch new therapy continue background therapy deem appropriate investigator . ] Both group also receive nelfinavir mesylate 2 NRTIs . All patient receive dose nelfinavir mesylate . The NRTIs select investigator 's discretion provide patient previously receive choose NRTIs . Patients regular physical examination . Blood sample collect regularly 1 month post-treatment determine plasma HIV RNA , pharmacokinetics , CD4 CD8 count . Patients complete 24 week treatment option continue treatment additional 24 week end participation .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible trial : Are HIVpositive . Have CD4 cell count 50/mm3 . Are least 18 year old . Have adequate blood , kidney , liver function . Are currently take antiHIV drug combination NNRTI plus 1 NRTIs 28 day fail combination . Exclusion Criteria Patients eligible trial : Have protease inhibitor capravirine treatment . Have give drug interferes immune system study drug within 28 day study entry . Have radiation therapy within 28 day study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2001</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Nelfinavir</keyword>
</DOC>